Real Estate / REIT - Healthcare FacilitiesTokyo
$107700.00
-2200.00 (-2.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 22.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
23/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$38.7B
P/E
19.0x
↑EV/EBITDA
21.9x
↑ROE
5.4%
↑Gross Margin
65.8%
↑Debt/Equity
1.08
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+6.2%
FCF CAGR
-33.9%
FCF margin
11.2%
FCF / Net income
0.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.95B · net income $2.10B · FCF $555.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.95B | $4.95B | $5.07B | $4.45B | $4.13B |
| Net Income | $2.10B | $2.10B | $2.35B | $2.01B | $1.83B |
| EBITDA | $3.57B | $3.57B | $3.72B | $3.24B | $2.97B |
| EPS | 5853.27 | 5853.27 | 6526.83 | 5999.13 | — |
| Gross Margin | 65.8% | 65.8% | 68.0% | 66.6% | 66.8% |
| Operating Margin | 51.5% | 51.5% | 53.7% | 52.5% | 52.0% |
| Net Margin | 42.5% | 42.5% | 46.3% | 45.2% | 44.3% |
| Balance Sheet | |||||
| Debt/Equity | 1.08 | 1.08 | 1.01 | 1.00 | 1.01 |
| Current Ratio | 0.36 | 0.36 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $555.7M | $555.7M | $2.36B | $-9.34B | $1.92B |
| Returns | |||||
| ROE | 5.4% | 5.4% | 6.1% | 5.2% | 5.6% |
| Valuation | |||||
| P/E | 19.05 | 19.05 | 22.83 | 28.30 | — |
| EV/EBITDA | 21.91 | 21.91 | 24.50 | 29.04 | 26.21 |
| P/B | 1.00 | 1.00 | 1.39 | 1.47 | 1.40 |
| Growth & Yield | |||||
| Revenue Growth | -2.3% | -2.3% | 13.9% | 7.8% | — |
| EPS Growth | -10.3% | -10.3% | 8.8% | — | — |
| Dividend Yield | 6.0% | 6.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
17.8%
EPS terminal req.
$9556.58
Spread vs growth
-28.1%
5Y implied EPS CAGR
14.6%
EPS terminal req.
$11563.46
Spread vs growth
-24.9%
10Y implied EPS CAGR
12.3%
EPS terminal req.
$18623.07
Spread vs growth
-22.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+4.6%
Start / end P/E
16.7x → 18.4x
EPS bridge
6526.83 → 5853.27
Residual
-1.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.